Monica Luminos
Biographic Data
| ID | 8261987 |
|---|---|
| NAME | Monica Luminos |
| GIVEN NAMES | Monica |
| FAMILY NAME | Luminos |
| SIGNATURE | LUMINOS M |
| AFFILIATIONS | Carol Davila University of Medicine and Pharmacy |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Remdesivir Efficacy and Tolerability in Children with Covid-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
In children, coronavirus disease 2019 (COVID-19) starts as a minor illness compared to adults, but during the ongoing COVID-19 pandemic, distinct SARS-CoV-2 variants and subvariants have changed options for therapies in both adults and children, especially for those with comorbidities such as allergies. On 25 April 2022, Remdesivir (RDV), a viral RNA-dependent RNA polymerase inhibitor, was approved by the Food and Drug Administration (FDA) for th…
No prominent works on this page.
Remdesivir Efficacy and Tolerability in Children with Covid-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
In children, coronavirus disease 2019 (COVID-19) starts as a minor illness compared to adults, but during the ongoing COVID-19 pandemic, distinct SARS-CoV-2 variants and subvariants have changed options for therapies in both adults and children, especially for those with comorbidities such as allergies. On 25 April 2022, Remdesivir (RDV), a viral RNA-dependent RNA polymerase inhibitor, was approved by the Food and Drug Administration (FDA) for th…
Adverse effect (1 work) · Allergy (1 work) · Asthma (1 work) · Atopic dermatitis (1 work) · Comorbidity (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Clinical Research Studies (1 work) · Disease (1 work) · Immunology (1 work) · Infectious disease (medical specialty (1 work)